Rich...International Conference on Emerging Cell Therapies...
Hemogenix CEO Ivan Rich (VODG's strategic partner) will deliver a keynote address/presentation at the 2012 International Conference on Emerging Cell Therapies (October 1, Chicago).
Subject matter of the presentation will be measurement of stem cell potency prior to therapeutic transplantation of the cells.